Real-time enrollment status for this parkinson's disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:12 AM UTC
| NCT Number | NCT06680830 |
| Recruiting Status | Recruiting |
| Condition | Parkinson's Disease |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 45 sites in the US |
| Sponsor | Neuron23 Inc. |
| Last Updated on CT.gov | July 1, 2026 (2 weeks ago) |
As of July 19, 2026: Clinical trial NCT06680830 is currently recruiting participants. This phase2 study for parkinson's disease is actively seeking new participants at 45 locations across the United States. The study is sponsored by Neuron23 Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06680830 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06680830 was last updated 2 weeks ago (July 1, 2026). HelloStudys verifies this status automatically.